Growth Metrics

Utah Medical Products (UTMD) Current Assets (2016 - 2025)

Utah Medical Products has reported Current Assets over the past 16 years, most recently at $97.7 million for Q4 2025.

  • Quarterly results put Current Assets at $97.7 million for Q4 2025, up 1.47% from a year ago — trailing twelve months through Dec 2025 was $97.7 million (up 1.47% YoY), and the annual figure for FY2025 was $97.7 million, up 1.47%.
  • Current Assets for Q4 2025 was $97.7 million at Utah Medical Products, up from $96.5 million in the prior quarter.
  • Over the last five years, Current Assets for UTMD hit a ceiling of $107.1 million in Q1 2024 and a floor of $66.6 million in Q1 2021.
  • Median Current Assets over the past 5 years was $95.7 million (2023), compared with a mean of $90.7 million.
  • Biggest five-year swings in Current Assets: surged 32.89% in 2021 and later fell 10.03% in 2025.
  • Utah Medical Products' Current Assets stood at $73.2 million in 2021, then grew by 22.91% to $89.9 million in 2022, then grew by 18.18% to $106.3 million in 2023, then dropped by 9.35% to $96.3 million in 2024, then grew by 1.47% to $97.7 million in 2025.
  • The last three reported values for Current Assets were $97.7 million (Q4 2025), $96.5 million (Q3 2025), and $94.4 million (Q2 2025) per Business Quant data.